UBS Cite Efficient Capital Allocation and Rising Profits in Viatris Inc. (VTRS) Upgrade
TheFly reported on February 9 that UBS upgraded VTRS to Buy from Neutral and raised the price target to $18 from $11.
Insider Monkey Blog
Barclays Cite Favorable Long-Term Outlook For Legend Biotech Corporation (LEGN) Despite Near-Term Expectation Revisions
TheFly reported on February 4 that Barclays lowered its price target on LEGN to $80 from $90 and maintained an Overweight rating on the shares. Although the long-term forecast...
BofA Highlights WVE-007 as Primary Driver For Wave Life Sciences Ltd. (WVE)’s Growth, Projecting Peak Sales Above $11B
TheFly reported on February 5 that Bank of America (BofA) initiated coverage of WVE with a Buy rating and a price target of $38.
Stifel Views Downtime as Attractive Entry Opportunity for Hinge Health, Inc. (HNGE) Shares
TheFly reported on February 5 that Stifel lowered its price target on HNGE to $59 from $66 and maintained a Buy rating on the shares.
Fiserv (FISV) Jumps Over 6% as Activist Investor Gobbles Stake
Fiserv grew its share prices by 6.89 percent on Tuesday to finish at $63.45 apiece as investors mirrored an activist group’s acquisition of a significant stake in a bid to boost...
Under Armour (UA) Surges 8.18% on Milestone Shoe Launch
Under Armour rallied for a third straight day on Tuesday, jumping 8.18 percent to finish at $7.54 apiece as investors resumed buying positions following the launch of its final...
Waystar (WAY) Climbs 8.5% on Swing to Profits, Double-Digit Outlook
Waystar saw its share prices jump by 8.48 percent on Tuesday to close at $24.31 apiece as investors cheered its swing to profitability and a double-digit growth outlook for this...
Kyndryl (KD) Soars 11% on Financial Statement Compliance
Kyndryl Holdings rallied for a second day on Tuesday, jumping 11.03 percent to finish at $13.59 apiece as investors resumed buying positions following the successful submission...
Norwegian Cruise (NCLH) Soars 12% as Activist Firm Buys Stake
Norwegian Cruise saw its share prices jump by 12.15 percent on Tuesday to finish at $24.10 apiece as investors mimicked an activist group’s acquisition of a 10 percent stake...
National Energy (NESR) Propels to All-Time High on Earnings Beat
In an updated report, National Energy Services Reunited Corp.
eToro (ELOR) Climbs 20% on Earnings Buyout, Buyback Hike
eToro grew its share prices by 20.43 percent on Tuesday to finish at $33.07 apiece as investors gobbled up shares following a strong earnings performance and news of a higher ...
ZIM Integrated (ZIM) Soars to Record High on $4.2-Billion Takeover
ZIM Integrated rallied to an over three-year high on Tuesday, as investors gobbled up shares following news that it was set to be acquired by German shipping giant Hapag-Lloyd...
Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks
TheFly reported on February 4 that Mizuho lowered its price target on WAY to $42 from $50 while maintaining an Outperform rating.
Deutsche Bank Cite Near-Term Growth Concerns For Hims & Hers Health, Inc. (HIMS) Following GLP-1 Launch Reversal
TheFly reported on February 10 that Deutsche Bank lowered its price target on HIMS to $31 from $42 and maintained a Hold rating on the shares.
Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81
TheFly reported on February 6 that Baird lowered its price target for HAE to $81 from $99 while maintaining an Outperform rating.
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside
TheFly reported on February 9 that Canaccord Genuity upgraded DOCS from Hold to Buy and lowered the price target to $34 from $48.
Truist Notes Operational Investments For Cytokinetics, Incorporated (CYTK) to Support Short-Term Growth
TheFly reported on February 3 that Truist raised its price target on CYTK to $92 from $84 and maintained a Buy rating. The company revised its model ahead of its Q4 results...
Travere Therapeutics, Inc. (TVTX) Positioned for Long-Term Growth in Rare Disease Market
TheFly reported on February 6 that Piper Sandler raised its price target on TVTX to $38 from $35 and maintained a Neutral rating on the shares.
Morgan Stanley Notes 2026 Sales From Arrowhead Pharmaceuticals, Inc. (ARWR)’s Familial Chylomicronemia Syndrome Likely Limited
TheFly reported on February 6 that Morgan Stanley lowered its price target for ARWR to $78 from $81 and kept an Equal Weight rating.
Oppenheimer Maintains A Balanced Outlook on ACADIA Pharmaceuticals Inc. (ACAD) For 2026
TheFly reported on February 6 that Oppenheimer raised its price target on ACAD to $23 from $21 and maintained a Perform rating on the shares.
BoFA Notes BridgeBio Pharma, Inc. (BBIO)’s Upcoming Q4 Earnings May Have Limited Market Impact
TheFly reported on February 3 that Bank of America analyst Jason Zemansky raised its price target on BBIO to $88 from $85 and maintained a Buy rating on the shares.
RBC Cites Stable Business Model For Concentra Group Holdings Parent, Inc. (CON) Amid Macroeconomic Volatility
TheFly reported on February 2 that RBC Capital raised its price target on CON to $31 from $30 and maintained an Outperform rating.
Baird’s Model Update Suggests Alignment Healthcare, Inc. (ALHC)’s Shares Could Reach $59
TheFly reported on January 30 that Baird increased its price target on ALHC to $28 from $22 while maintaining an Outperform rating. After updating its financial model, the...
Clear Eyes Supply Disruption Weighs on Prestige Consumer Healthcare Inc. (PBH)’s Quarterly Revenue
TheFly reported on February 6 that Canaccord reduced its price target on PBH to $86 from $88 and maintained a Buy rating on the shares. The change came after the company...
Seaport Research Downgrades Sirius XM Holdings Inc. (SIRI) to Neutral
On February 6, 2026, Seaport Research downgraded Sirius XM Holdings Inc. (NASDAQ:SIRI) to Neutral from Buy and removed its price target.
Roth Capital Raises its Price Target on TKO Group Holdings, Inc. (TKO) to $240 and Maintains a Buy Rating
On February 12, 2026, Roth Capital raised its price target on TKO Group Holdings, Inc. (NYSE:TKO) to $240 from $210 and maintained a Buy rating.
Morgan Stanley Raises its Price Target on Sphere Entertainment Co. (SPHR) to $135 and Maintains an Overweight Rating
On February 13, 2026, Morgan Stanley raised its price target on Sphere Entertainment Co.
Roth Capital Lowers its Price Target on Live Nation Entertainment, Inc. (LYV) to $174 and Maintains a Buy Rating
On February 12, 2026, Roth Capital lowered its price target on Live Nation Entertainment, Inc. (NYSE:LYV) to $174 from $176 and maintained a Buy rating.
Citi Raised its Price Target on Madison Square Garden Sports Corp. (MSGS) to $337 and Maintains a Buy Rating
On February 13, 2026, Citi analyst Jason Bazinet raised his price target on Madison Square Garden Sports Corp. (NYSE:MSGS) to $337 from $290 and maintained a Buy rating.
Warner Music Group Corp. (WMG) Reports First-Quarter Revenue of $1.84 Billion, Above Consensus
On February 5, 2026, Warner Music Group Corp. (NASDAQ:WMG) reported first-quarter revenue of $1.84 billion, above the $1.77 billion consensus estimate.
California Attorney General Announces $2.75M CCPA Settlement With The Walt Disney Company (DIS)
On February 13, 2026, California Attorney General Rob Bonta announced a $2.75 million settlement with The Walt Disney Company (NYSE:DIS) over allegations that it violated the ...
Evercore ISI Raises its Price Target on Fox Corporation (FOX) to $70 and Maintains an In Line Rating
On February 5, 2026, Evercore ISI raised its price target on Fox Corporation (NASDAQ:FOX) to $70 from $66 previously and maintained an In Line rating following what it described...
Paramount Skydance Corporation (PSKY) in Talks with Pentwater Founder Matthew Halbower Over Potential Warner Bros. Discovery Board Seat
On February 12, 2026, Reuters reported that Paramount Skydance Corporation (NASDAQ:PSKY) is in talks with Matthew Halbower, founder of Pentwater Capital Management and the seventh...
Pivotal Research Raises its Price Target on Roku, Inc. (ROKU) to $140 and Maintains a Buy Rating
On February 16, 2026, Pivotal Research raised its price target on Roku, Inc.
Morgan Stanley Lowers its Price Target on News Corporation (NWS) to $32.40 and Maintains an Overweight Rating
On February 6, 2026, Morgan Stanley lowered its price target on News Corporation (NASDAQ:NWS) to $32.40 from $38 previously and maintained an Overweight rating, updating estimates...
Roth Capital is Bullish on Bitdeer Technologies Group (BTDR)
On February 13, Darren Aftahi of Roth Capital decreased Bitdeer Technologies Group (NASDAQ:BTDR)'s price target from $40 to $30.
Macquarie Maintains an Outperform Rating on CleanSpark, Inc. (CLSK)
Separately, Keefe Bruyette maintained its Outperform rating on the stock and trimmed its price target from $18 to $14 on February 9, 2026.
Morgan Stanley Initiates Coverage on MARA Holdings, Inc. (MARA)
On February 9, Morgan Stanley started coverage of MARA Holdings, Inc. (NASDAQ:MARA) with an Underweight rating and an $8 price target.
Roth Believes that Another Hyperscaler Lease is ‘Imminent’ for Applied Digital Corporation (APLD)
Roth Capital said that Applied Digital has started construction on Delta Forge 1, its AI Factory campus in a strategic southern U.S.
Is Cipher Mining Inc. (CIFR) among the Best Bitcoin and Blockchain Stocks to Invest in?
Cipher Mining Inc. (NASDAQ:CIFR) named Drew Armstrong as Head of Strategic Initiatives and Lee Bratcher as Head of Policy and Government Affairs on January 6, 2026.
Morgan Stanley Starts Coverage on TeraWulf Inc. (WULF)
Morgan Stanley started coverage on TeraWulf Inc. (NASDAQ:WULF) on February 9, 2026, with an Overweight rating and a $37 price target.
H.C. Wainwright is Bullish on Hut 8 Corp. (HUT)
On February 2, H.C. Wainwright analyst Kevin Dede commenced coverage of Hut 8 Corp. (NASDAQ:HUT) while assigning it a Buy rating and a price target of $80.
Impax US Sustainable Economy Fund’s Q4 2025 Investor Letter
Impax Asset Management's "Impax US Sustainable Economy Fund" released its Q4 2025 investor letter.
AI Integration and New Partnerships Drive The Real Brokerage Inc. (REAX) Forward
The Real Brokerage Inc. (NASDAQ:REAX) is one of the best high-return penny stocks to buy right now. On January 27, The Real Brokerage Inc.
Altimmune, Inc. (ALT) Gains Analyst Support as Pemvidutide Advances
Altimmune, Inc. (NASDAQ:ALT) is one of the best high-return penny stocks to buy right now. On February 13, Titan Partners initiated coverage of Altimmune, Inc.
Rezolve AI PLC (RZLV) Sets Sights on Agentic Commerce Opportunities
Rezolve AI PLC (NASDAQ:RZLV) is one of the best high-return penny stocks to buy right now. On February 11, H.C.
This is Why Fubotv Inc. (FUBO) is a Buy After Pull Back
Fubotv Inc. (NYSE:FUBO) is one of the best high-return penny stocks to buy right now. On February 5, analysts at Seaport Global Securities upgraded Fubotv Inc.
Opko Health Inc. (OPK) Builds Value Through Partnerships and Innovation
Opko Health Inc. (NASDAQ:OPK) is one of the best high-return penny stocks to buy right now. On February 10, analysts at H.C.
Hedge Fund Resource Center
